Table 2 Correlation between clinicopathological features and NLR and LMR in 239 all breast cancers
Parameters | NLR | p value | LMR | p value | ||
|---|---|---|---|---|---|---|
High (n = 165, 69.0%) | Low (n = 74, 31.0%) | High (n = 119, 49.8%) | Low (n = 120, 50.2%) | |||
Age at operation | ||||||
  ≤ 56 | 95 (57.6%) | 22 (29.7%) | < 0.001 | 47 (39.5%) | 70 (58.3%) | 0.004 |
  > 56 | 70 (42.4%) | 52 (70.3%) | 72 (60.5%) | 50 (41.7%) | ||
Menopause | ||||||
 Pre- | 78 (47.3%) | 17 (23.0%) | < 0.001 | 37 (31.1%) | 58 (48.3%) | 0.008 |
 Post- | 87 (52.7%) | 57 (77.0%) | 82 (68.9%) | 62 (51.7%) | ||
Tumor size | ||||||
  ≤ 2 cm | 23 (13.9%) | 9 (12.2%) | 0.838 | 10 (8.4%) | 22 (18.3%) | 0.036 |
  > 2 cm | 142 (86.1%) | 65 (87.8%) | 109 (91.6%) | 98 (81.7%) | ||
Lymph node status | ||||||
 Negative | 42 (25.5%) | 24 (32.4%) | 0.277 | 36 (30.3%) | 30 (25.0%) | 0.388 |
 Positive | 123 (74.5%) | 50 (67.6%) | 83 (69.7%) | 90 (75.0%) | ||
Nuclear grade | ||||||
 1, 2 | 132 (80.0%) | 63 (85.1%) | 0.373 | 99 (82.5%) | 96 (80.7%) | 0.741 |
 3 | 33 (20.0%) | 11 (14.9%) | 21 (17.5%) | 23 (19.3%) | ||
Ki67 | ||||||
  ≤ 14% | 53 (32.1%) | 26 (35.1%) | 0.658 | 35 (29.4%) | 44 (36.7%) | 0.272 |
  > 14% | 112 (67.9%) | 48 (64.9%) |  | 84 (70.6%) | 76 (63.3%) |  |
Intrinsic subtype | ||||||
 TNBC | 60 (36.4%) | 23 (31.1%) | 0.465 | 40 (33.6%) | 43 (35.8%) | 0.719 |
 Non-TNBC | 105 (63.6%) | 51 (68.9%) | 79 (66.4%) | 77 (64.2%) | ||
Pathological response | ||||||
 pCR | 69 (41.8%) | 22 (29.7%) | 0.085 | 46 (38.3%) | 45 (37.8%) | 0.934 |
 non-pCR | 96 (58.2%) | 52 (70.3%) | 74 (61.7%) | 74 (62.2%) | ||